Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Jia-Nan Chen, Jia-Cheng Jin, Juan Guo, Ying Tao, Fan-Huan Xu, Qi Liu, Xiao Li, Chun-Kang Chang & Ling-Yun Wu. (2023) The bcl6 corepressor mutation regulates the progression and transformation of myelodysplastic syndromes by repressing the autophagy flux. The International Journal of Biochemistry & Cell Biology 165, pages 106480.
Crossref
Crossref
Dai Li, Xueqiang Peng, Guangpeng He, Jiaxing Liu, Xian Li, Weikai Lin, Jianjun Fang, Xinyu Li, Shuo Yang, Liang Yang & Hangyu Li. (2023) Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications. Cell Death & Disease 14:7.
Crossref
Crossref
Jose Silva, Jiyang Yu & Kevin Kalinsky. (2023) Reply to: Ricolinostat is not a highly selective HDAC6 inhibitor. Nature Cancer 4:6, pages 809-811.
Crossref
Crossref
Bei Liu, Jiaxi Zhang, Xue Meng, Shelly M. Xie, Fang Liu, Heli Chen, Demin Yao, Minglei Li, Minghui Guo, Haitao Shen, Xianghong Zhang & Lingxiao Xing. (2023) HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer. Oncogene 42:15, pages 1181-1195.
Crossref
Crossref
Yi-Chao Zheng, Hui-Qin Kang, Bo Wang, Yuan-Zai Zhu, M.A.A. Mamun, Long-Fei Zhao, Hai-Qian Nie, Ying Liu, Li-Juan Zhao, Xiao-Nan Zhang, Mei-Mei Gao, Dan-Dan Jiang, Hong-Min Liu & Ya Gao. (2023) Curriculum vitae of HDAC6 in solid tumors. International Journal of Biological Macromolecules 230, pages 123219.
Crossref
Crossref
Wen-Jie Fan, Meng-Xi Zhou, Di-Di Wang, Xin-Xin Jiang & Hao Ding. (2023) TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Genetics and Molecular Biology 46:2.
Crossref
Crossref
Sameer Ullah Khan, Sheikh Rayees, Pankaj Sharma & Fayaz Malik. (2022) Targeting redox regulation and autophagy systems in cancer stem cells. Clinical and Experimental Medicine.
Crossref
Crossref
Mengling Wu, Qianrui Huang, Mengya Liao, Xuyi Wu, Huizhi Xi, Hongbo Ma, Shanrui Li, Yiwen Zhang & Yong Xia. (2022) OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis. Cellular Oncology.
Crossref
Crossref
Yanfei He, Huaqing Lu & Yuting Zhao. (2022) Development of an autophagy activator from Class III PI3K complexes, Tat-BECN1 peptide: Mechanisms and applications. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Hyein Jo, Kyeonghee Shim & Dooil Jeoung. (2022) Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance. International Journal of Molecular Sciences 23:17, pages 9592.
Crossref
Crossref
Marcela Oliveira Tavares, Thaís Moré Milan, Rayana Longo Bighetti‐Trevisan, Andréia Machado Leopoldino & Luciana Oliveira de Almeida. (2022) Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 51:6, pages 529-537.
Crossref
Crossref
Xuefeng Pang, Qigang Guan, Xue Lin & Ning Chang. (2022) Knockdown of HDAC6 alleviates ventricular remodeling in experimental dilated cardiomyopathy via inhibition of NLRP3 inflammasome activation and promotion of cardiomyocyte autophagy. Cell Biology and Toxicology.
Crossref
Crossref
Ali Salimi-Jeda, Soad Ghabeshi, Zeinab Gol Mohammad pour, Ehsan Ollah Jazaeri, Mehrdad Araiinejad, Farzaneh Sheikholeslami, Mohsen Abdoli, Mahdi Edalat & Asghar Abdoli. (2022) Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy. Cancer Treatment and Research Communications 30, pages 100512.
Crossref
Crossref
Daniela Trisciuoglio & Francesca Degrassi. (2021) The Tubulin Code and Tubulin-Modifying Enzymes in Autophagy and Cancer. Cancers 14:1, pages 6.
Crossref
Crossref
Seong-Jun Park, Sang Hoon Joo, Naeun Lee, Won-Jun Jang, Ji Hae Seo & Chul-Ho Jeong. (2021) ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy. Archives of Pharmacal Research 44:12, pages 1062-1075.
Crossref
Crossref
Zhiyong Zhang, Xin Zhang & Aimin Huang. (2021) Aggresome–Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Qian Zhang, Chunmiao Jiang, Wenhao Ren, Shaoming Li, Jingjing Zheng, Yuli Gao, Keqian Zhi & Ling Gao. (2021) Circ‐LRP6 mediates epithelial‐mesenchymal transition and autophagy in oral squamous cell carcinomas. Journal of Oral Pathology & Medicine 50:7, pages 660-667.
Crossref
Crossref
Harpreet K Mandhair, Urban Novak & Ramin Radpour. (2021) Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells. World Journal of Stem Cells 13:6, pages 542-567.
Crossref
Crossref
Mianmian Liao, Caiwei Wang, Bowen Yang, Danping Huang, Yifeng Zheng, Shengqi Wang, Xuan Wang, Juping Zhang, Chunbian Tang, Zheng Xu, Yu He, Ruolin Huang, Fengxue Zhang, Zhiyu Wang & Neng Wang. (2021) Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis. Frontiers in Pharmacology 12.
Crossref
Crossref
Kayode Ezekiel Adewole & Ahmed Adebayo Ishola. (2021) A Computational Approach to Investigate the HDAC6 and HDAC10 Binding Propensity of Psidium guajava-derived Compounds as Potential Anticancer Agents. Current Drug Discovery Technologies 18:3, pages 423-436.
Crossref
Crossref
Mussa Yussuf Khamis, Hui-Pan Wu, Qin Ma, Yi-Han Li, Li-Ying Ma, Xin-Hui Zhang & Hong-Min Liu. (2021) Overcome the tumor immunotherapy resistance by combination of the HDAC6 inhibitors with antitumor immunomodulatory agents. Bioorganic Chemistry 109, pages 104754.
Crossref
Crossref
Xiaocong Xiang, Yunhong Tian, Jiani Hu, Rong Xiong, Matthew Bautista, Li Deng, Qiuju Yue, Yuqi Li, Wei Kuang, Junfeng Li, Kang Liu, Chunlei Yu & Gang Feng. (2021) Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway. Biochemical Pharmacology 186, pages 114475.
Crossref
Crossref
He-Ming Zhou, Ji-Gang Zhang, Xue Zhang & Qin Li. (2021) Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Yunyan Zhan, Haisheng Wang, Lu Zhang, Fei Pei & Zhi Chen. (2020) HDAC6 Regulates the Fusion of Autophagosome and Lysosome to Involve in Odontoblast Differentiation. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Jaione Auzmendi-Iriarte, Ander Saenz-Antoñanzas, Idoia Mikelez-Alonso, Estefania Carrasco-Garcia, Maitena Tellaetxe-Abete, Charles H. Lawrie, Nicolás Sampron, Aitziber L. Cortajarena & Ander Matheu. (2020) Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma. Cell Death & Disease 11:6.
Crossref
Crossref
Namrata Bora-Singhal, Durairaj Mohankumar, Biswarup Saha, Christelle M. Colin, Jennifer Y. Lee, Matthew W. Martin, Xiaozhang Zheng, Domenico Coppola & Srikumar Chellappan. (2020) Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2. Scientific Reports 10:1.
Crossref
Crossref
Minjeong Yeon, Seungheon Lee, Joo-Eun Lee, Hyun Suk Jung, Youngmi Kim & Dooil Jeoung. (2019) CAGE-miR-140-5p-Wnt1 Axis Regulates Autophagic Flux, Tumorigenic Potential of Mouse Colon Cancer Cells and Cellular Interactions Mediated by Exosomes. Frontiers in Oncology 9.
Crossref
Crossref